Signature Talk · 01

The AI Advantage - Keynote by Gina Malak

How organizations can leverage AI before their competitors do.

Ideal audience · Executives · Government · Healthcare
Overview

What this talk is about

The AI Advantage is Gina Malak's signature executive keynote on turning AI curiosity into AI execution. Leaders leave with a repeatable framework for spotting high-value AI use cases, running lightweight pilots, and scaling what works - without stalling on hype, governance fear, or vendor confusion.

Audience takeaways

What your audience walks away with.

  • A 3-step framework to prioritize AI use cases by business impact
  • How to run a 30-day AI pilot without a data-science team
  • Governance guardrails that accelerate - not block - adoption
  • How to communicate AI wins to boards, regulators, and the workforce
Formats

Available as

  • 30-min Keynote
  • 60-min Interactive Session
  • Half-Day Workshop
Ideal for

Best fit events

  • C-suite leadership summits
  • Healthcare and hospital executive retreats
  • Government innovation events
  • Industry association conferences

Bring The AI Advantage to your stage.

Email Gina with your event date, audience, and format. Every talk is customized - never a recycled deck.

hello@flippinginnovations.com
FAQ

Questions about this talk

Who is 'The AI Advantage' keynote for?+

Executives, board members, and senior leaders in healthcare, government, and enterprise who need a concrete framework - not hype - for AI adoption.

Do audience members need a technical background?+

No. Gina translates AI strategy into business terms and delivers frameworks any executive can act on the next morning.

How long is the keynote?+

Available as a 30-minute keynote, a 60-minute interactive session with Q&A, and a half-day executive workshop that produces a prioritized AI use-case list.

Is the content customized to our industry?+

Yes. Gina interviews the host organization beforehand and rebuilds examples, case studies, and frameworks around your industry and audience.